Skip to main content

Main menu

  • Home
  • Current issue
  • ERJ Early View
  • Past issues
  • ERS Guidelines
  • Authors/reviewers
    • Instructions for authors
    • Submit a manuscript
    • Open access
    • Peer reviewer login
  • Alerts
  • Subscriptions
  • ERS Publications
    • European Respiratory Journal
    • ERJ Open Research
    • European Respiratory Review
    • Breathe
    • ERS Books
    • ERS publications home

User menu

  • Log in
  • Subscribe
  • Contact Us
  • My Cart
  • Log out

Search

  • Advanced search
  • ERS Publications
    • European Respiratory Journal
    • ERJ Open Research
    • European Respiratory Review
    • Breathe
    • ERS Books
    • ERS publications home

Login

European Respiratory Society

Advanced Search

  • Home
  • Current issue
  • ERJ Early View
  • Past issues
  • ERS Guidelines
  • Authors/reviewers
    • Instructions for authors
    • Submit a manuscript
    • Open access
    • Peer reviewer login
  • Alerts
  • Subscriptions

Additional important research priorities for bronchiectasis in China

Wei-jie Guan, Yong-hua Gao, Jing-jing Yuan, Rong-chang Chen, Nan-shan Zhong
European Respiratory Journal 2017 49: 1601747; DOI: 10.1183/13993003.01747-2016
Wei-jie Guan
1State Key Laboratory of Respiratory Disease, National Clinical Research Center for Respiratory Disease, Guangzhou Institute of Respiratory Disease, First Affiliated Hospital of Guangzhou Medical University, Guangzhou Medical University, Guangzhou, China
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Yong-hua Gao
2Dept of Respiratory and Critical Care Medicine, First Affiliated Hospital of Zhengzhou University, Zhengzhou, China
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jing-jing Yuan
1State Key Laboratory of Respiratory Disease, National Clinical Research Center for Respiratory Disease, Guangzhou Institute of Respiratory Disease, First Affiliated Hospital of Guangzhou Medical University, Guangzhou Medical University, Guangzhou, China
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Rong-chang Chen
1State Key Laboratory of Respiratory Disease, National Clinical Research Center for Respiratory Disease, Guangzhou Institute of Respiratory Disease, First Affiliated Hospital of Guangzhou Medical University, Guangzhou Medical University, Guangzhou, China
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: chenrc@vip.163.com
Nan-shan Zhong
1State Key Laboratory of Respiratory Disease, National Clinical Research Center for Respiratory Disease, Guangzhou Institute of Respiratory Disease, First Affiliated Hospital of Guangzhou Medical University, Guangzhou Medical University, Guangzhou, China
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Info & Metrics
  • PDF
Loading

Abstract

Aetiology, Chinese medicine, phenotyping, fertility and comorbidities of bronchiectasis should be studied in China http://ow.ly/tiJl304s5j0

To the Editor:

We highly appreciate the laudable desire of the European Multicentre Bronchiectasis Audit and Research Collaboration (EMBARC) [1] to provoke research interests and develop study protocols to investigate bronchiectasis, a disease which has not yet received sufficient attention worldwide, particularly in China. China is a major developing country with a large population; however, there is a lack of epidemiological investigations detailing the prevalence or incidence of bronchiectasis. While we totally concur with the recommendations from European experts, we feel that additional priorities in bronchiectasis should be highlighted for future research in China.

1) Regional distribution of bronchiectasis aetiology throughout China. The aetiological investigations published to date were mainly based in major cities such as Shanghai [2], Guangzhou [3], and Jinan [4]. The prevalence of pulmonary infections (e.g. tuberculosis, measles and pertussis) are expected to be significantly higher in rural areas because of the limited medical resources. Our understanding has been hampered by the lack of official documentation regarding regional distributions of bronchiectasis aetiologies in China. Future investigations are warranted to prioritise our national healthcare plan for disease control.

2) The role of traditional Chinese medicine in bronchiectasis patients. The long Chinese history has nurtured the development of traditional Chinese medicine, a delicate medical system which is still regarded as a tremendous treasure trove that is complementary to western medicine. In fact, a considerable number of bronchiectasis patients report that they have actively sought consultation from experts in traditional Chinese medicine. Patients had greater willingness to receive therapy with Chinese herbal compounds (typically for decoction) to minimise the potential adverse effects of western medicine (W.J. Guan and co-workers; unpublished data). To our knowledge, the efficacy of Chinese herbs for improving asthma control has been documented [5]. We strongly feel that Chinese herbs may have a role in future management of bronchiectasis, for instance, by reducing the frequency of bronchiectasis exacerbations. However, in light of the lack of evidence-based reports, well-designed randomised, double-blind clinical trials are needed to thoroughly validate the efficacy and safety of Chinese herbs for bronchiectasis.

3) The role of clinical phenotyping in improving management of bronchiectasis. The significant heterogeneity of clinical manifestations of bronchiectasis has been increasingly recognised. Clinical phenotyping using unsupervised learning techniques [6, 7] has provided researchers with an invaluable opportunity to personalise therapy. Despite the absence of “gold standard criteria” for classification of clusters, clinical phenotyping is complementary to disease severity assessment because it takes into account both the homogeneity and heterogeneity of bronchiectasis. To justify bronchiectasis phenotyping, it would be useful to investigate its added value to improve therapeutic outcomes and long-term prognosis.

4) The impact of bronchiectasis on fertility. Compared with Caucasians [6, 8, 9], Chinese bronchiectasis patients are significantly younger at enrolment [2–4, 7]. The mean age of our cohort was 44.5 years [6], and ∼62% of females were still of child-bearing age. Currently, no report documenting whether bronchiectasis decreased fertility has been published. Nonetheless, clinicians have been frequently confronted with fertility counselling for bronchiectasis patients. It has become increasingly urgent to solve this issue after the implementation of the two-child policy in China [10]. In our pilot study (W.J. Guan and co-workers; unpublished data), most female patients demonstrated varying magnitudes of concern about infertility associated with bronchiectasis, despite the fact that most females successfully gave birth to healthy infants. Concerns about infertility have cast a considerable shadow over patient's daily life, leading to the development of anxiety and/or depression. Addressing the impact of bronchiectasis on fertility may help advance future healthcare in terms of adding further evidence to genetic counselling and mitigating patient's anxiety or depression.

5) Pathophysiological pathways leading to bronchiectasis–chronic obstructive pulmonary disease (COPD) and bronchiectasis–asthma overlap syndrome. There are various aetiologies underlying the pathogenesis of bronchiectasis. In the British Thoracic Society guidelines [11], COPD or asthma should be considered as the underlying aetiology of bronchiectasis. It should also be recognised that the determination of aetiology is challenging in most patients, but the overlap of bronchiectasis with asthma or COPD can be assessed using simple tools such as lung function tests. Current knowledge indicates that bronchiectasis may have common pathways with asthma (e.g. eosinophilic and/or neutrophilic inflammation) and COPD (e.g. neutrophilic and/or macrophagic inflammation). Bronchiectasis can be readily identified in a considerable number of COPD and asthmatic patients using high-resolution chest computed tomography, particularly in those with a prolonged course of disease. How primary or secondary aetiologies stimulate exaggerated neutrophilic responses leading to relentless degradation of the matrices of bronchial mucosa remains an area of profound interest. Unravelling the most useful biomarkers (e.g. periostin or fractional exhaled nitric oxide) to classify the clinical clusters and predict prognosis would provide clinicians with practical tools for disease intervention and management.

These additional research priorities in China may have complementary significance to the statement from the EMBARC Clinical Research Collaboration [1]. Researchers from China keenly await collaboration with colleagues from western countries to collectively solve the unanswered questions associated with bronchiectasis management.

Disclosures

Supplementary Material

R-C. Chen ERJ-01747-2016_Chen

W-J. Guan ERJ-01747-2016_Guan

N-S. Zhong ERJ-01747-2016_Zhong

Acknowledgements

Author contributions: W.J.G., Y.H.G. and J.J.Y. drafted the manuscript; R.C.C. and N.S.Z. critically reviewed the manuscript and approved final submission.

Footnotes

  • Support statement: Changjiang Scholars and Innovative Research Team in University (grant number: ITR0961), the National Key Technology R&D Program of the 12th National Five-year Development Plan (grant number: 2012BAI05B01) and National Key Scientific & Technology Support Program: Collaborative innovation of Clinical Research for chronic obstructive pulmonary disease and lung cancer grant number 2013BAI09B09 (to N.S. Zhong and R.C. Chen), National Natural Science Foundation (grant number: 81400010), and 2014 Scientific Research Projects for Medical Doctors and Researchers from Overseas, Guangzhou Medical University grant number 2014C21 (to W.J. Guan). Funding information for this article has been deposited with the Open Funder Registry.

  • Conflict of interest: Disclosures can be found alongside this article at erj.ersjournals.com

  • Received September 1, 2016.
  • Accepted September 2, 2016.
  • Copyright ©ERS 2017

References

  1. ↵
    1. Aliberti S,
    2. Masefield S,
    3. Polverino E, et al.
    Research priorities in bronchiectasis: a consensus statement from the EMBARC Clinical Research Collaboration. Eur Respir J 2016; 48: 632–647.
    OpenUrlAbstract/FREE Full Text
  2. ↵
    1. Mao B,
    2. Yang JW,
    3. Lu HW, et al.
    Asthma and bronchiectasis exacerbation. Eur Respir J 2016; 47: 1680–1686.
    OpenUrlAbstract/FREE Full Text
  3. ↵
    1. Guan WJ,
    2. Gao YH,
    3. Xu G, et al.
    Aetiology of bronchiectasis in Guangzhou, southern China. Respirology 2015; 20: 739–748.
    OpenUrlCrossRefPubMed
  4. ↵
    1. Qi Q,
    2. Wang W,
    3. Li T, et al.
    Aetiology and clinical characteristics of patients with bronchiectasis in a Chinese Han population: a prospective study. Respirology 2015; 20: 917–924.
    OpenUrlCrossRefPubMed
  5. ↵
    1. Wen MC,
    2. Wei CH,
    3. Hu ZQ, et al.
    Efficacy and tolerability of anti-asthma herbal medicine intervention in adult patients with moderate-severe allergic asthma. J Allergy Clin Immunol 2005; 116: 517–524.
    OpenUrlCrossRefPubMedWeb of Science
  6. ↵
    1. Aliberti S,
    2. Lonni S,
    3. Dore S, et al.
    Clinical phenotypes in adult patients with bronchiectasis. Eur Respir J 2016; 47: 1113–1122.
    OpenUrlAbstract/FREE Full Text
  7. ↵
    1. Guan WJ,
    2. Jiang M,
    3. Gao YH, et al.
    Unsupervised learning technique identifies bronchiectasis phenotypes with distinct clinical characteristics. Int J Tuberc Lung Dis 2016; 20: 402–410.
    OpenUrl
  8. ↵
    1. McDonnell MJ,
    2. Aliberti S,
    3. Goeminne PC, et al.
    Multidimensional severity assessment in bronchiectasis: an analysis of seven European cohorts. Thorax 2016; in press [DOI: 10.1136/thoraxjnl-2016-208481].
  9. ↵
    1. Chalmers JD,
    2. Smith MP,
    3. McHugh BJ, et al.
    Short- and long-term antibiotic treatment reduces airway and systemic inflammation in non-cystic fibrosis bronchiectasis. Am J Respir Crit Care Med 2012; 186: 657–665.
    OpenUrlCrossRefPubMedWeb of Science
  10. ↵
    Sina English. Two-child policy is a turning point for China. http://english.sina.com/china/2015/1030/860727.html Date last accessed: September 28, 2016. Date last updated: October 31, 2015.
  11. ↵
    1. Pasteur MC,
    2. Bilton D,
    3. Hill AT et al.
    British Thoracic Society guideline for non-CF bronchiectasis. Thorax 2010; 65: Suppl., i1–i58.
    OpenUrlAbstract/FREE Full Text
View Abstract
PreviousNext
Back to top
View this article with LENS
Vol 49 Issue 1 Table of Contents
European Respiratory Journal: 49 (1)
  • Table of Contents
  • Index by author
Email

Thank you for your interest in spreading the word on European Respiratory Society .

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Additional important research priorities for bronchiectasis in China
(Your Name) has sent you a message from European Respiratory Society
(Your Name) thought you would like to see the European Respiratory Society web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Print
Citation Tools
Additional important research priorities for bronchiectasis in China
Wei-jie Guan, Yong-hua Gao, Jing-jing Yuan, Rong-chang Chen, Nan-shan Zhong
European Respiratory Journal Jan 2017, 49 (1) 1601747; DOI: 10.1183/13993003.01747-2016

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero

Share
Additional important research priorities for bronchiectasis in China
Wei-jie Guan, Yong-hua Gao, Jing-jing Yuan, Rong-chang Chen, Nan-shan Zhong
European Respiratory Journal Jan 2017, 49 (1) 1601747; DOI: 10.1183/13993003.01747-2016
del.icio.us logo Digg logo Reddit logo Technorati logo Twitter logo CiteULike logo Connotea logo Facebook logo Google logo Mendeley logo
Full Text (PDF)

Jump To

  • Article
    • Abstract
    • Disclosures
    • Acknowledgements
    • Footnotes
    • References
  • Info & Metrics
  • PDF
  • Tweet Widget
  • Facebook Like
  • Google Plus One

More in this TOC Section

Agora

  • Airway immune responses to COVID-19 vaccination in COPD patients
  • Wider access to rifapentine-based regimens is needed for TB care globally
  • Screening for PVOD in heterozygous EIF2AK4 variant carriers
Show more Agora

Correspondence

  • Endothelial to mesenchymal transition as novel feature of pulmonary fibrosis
  • Transitioning endothelial cells contribute to pulmonary fibrosis
  • Treatable traits in ILD: why not consider acute exacerbations?
Show more Correspondence

Related Articles

Navigate

  • Home
  • Current issue
  • Archive

About the ERJ

  • Journal information
  • Editorial board
  • Press
  • Permissions and reprints
  • Advertising

The European Respiratory Society

  • Society home
  • myERS
  • Privacy policy
  • Accessibility

ERS publications

  • European Respiratory Journal
  • ERJ Open Research
  • European Respiratory Review
  • Breathe
  • ERS books online
  • ERS Bookshop

Help

  • Feedback

For authors

  • Instructions for authors
  • Publication ethics and malpractice
  • Submit a manuscript

For readers

  • Alerts
  • Subjects
  • Podcasts
  • RSS

Subscriptions

  • Accessing the ERS publications

Contact us

European Respiratory Society
442 Glossop Road
Sheffield S10 2PX
United Kingdom
Tel: +44 114 2672860
Email: journals@ersnet.org

ISSN

Print ISSN:  0903-1936
Online ISSN: 1399-3003

Copyright © 2023 by the European Respiratory Society